圆锥角膜
角膜曲率计
医学
眼科
视力
角膜胶原交联
前瞻性队列研究
Scheimpflug原理
外科
角膜
作者
Emilia Felter,Ramin Khoramnia,Maximilian Friedrich,Hyeck-Soo Son,Gerd U. Auffarth,Victor A. Augustin
标识
DOI:10.1007/s00417-024-06549-z
摘要
Abstract Purpose To evaluate the biomechanical and tomographic outcomes of keratoconus patients up to four years after corneal crosslinking (CXL). Methods In this longitudinal retrospective-prospective single-center case series, the preoperative tomographic and biomechanical results from 200 keratoconus eyes of 161 patients undergoing CXL were compared to follow-up examinations at three-months, six-months, one-year, two-years, three-years, and four-years after CXL. Primary outcomes included the Corvis Biomechanical Factor (CBiF) and five biomechanical response parameters obtained from the Corvis ST. Tomographically, the Belin-Ambrósio deviation index (BAD-D) and the maximal keratometry (K max ) measured by the Pentacam were analyzed. Additionally, Corvis E-staging, the thinnest corneal thickness (TCT), and the best-corrected visual acuity (BCVA) were obtained. Primary outcomes were compared using a paired t-test. Results The CBiF decreased significantly at the six-month ( p < 0.001) and one-year ( p < 0.001) follow-ups when compared to preoperative values. E-staging behaved accordingly to the CBiF. Within the two- to four-year follow-ups, the biomechanical outcomes showed no significant differences when compared to preoperative. Tomographically, the BAD-D increased significantly during the first year after CXL with a maximum at six-months ( p < 0.001), while K max decreased significantly ( p < 0.001) and continuously up to four years after CXL. The TCT was lower at all postoperative follow-up visits compared to preoperative, and the BCVA improved. Conclusion In the first year after CXL, there was a temporary progression in both the biomechanical CBiF and E-staging, as well as in the tomographic analysis. CXL contributes to the stabilization of both the tomographic and biomechanical properties of the cornea up to four years postoperatively.
科研通智能强力驱动
Strongly Powered by AbleSci AI